Thierry Chignon
Senior Partner @ Mérieux Equity Partners
Lyon, France
Thierry Chignon is a funding round investor at Mérieux Equity Partners in Lyon focused on Beauty and Cannabis. Thierry Chignon has more than 25 years of experience in Quality Assurance, Regulatory Affairs, Clinical Trials with particular focus on the medical device sector, including a first experience as Head Pharmacist with Institut Mérieux (10 years).As Director with Quintiles Consulting, between 1997 and 2006, he defined and participated in theimplementation of business development strategies for innovative products in Europe. Thierry also worked for 5 years as an expert of the Commission of the European Union drafting Guidelines and Regulations for medical devices. He has chaired standardization working groups in CEN and ISO, as well as a Eucomed Task Force on Tissue engineering.In 2006, Thierry joined Matignon Investissement to raise and deploy the first French fund dedicated to European medical technologies (Matignon Technologies II, 80M€). After several positive exits (trade sale and IPOs), Thierry joined Mérieux Développement in 2014. Thierry holds a Pharmacy Degree, PharmD, a Master Degree from IEP Paris (Sciences Politiques), and an executive MBA from HEC Paris.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Thierry Chignon invests in
Stages Thierry Chignon invests in
Countries Thierry Chignon invests in
Investment Focus
Industry
- Beauty 1 (25%)
- Cannabis 1 (25%)
- Veterinary 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Laboratoires Ineldea
|
Created by a management team with more than 20 years' experience in the field of natural products, Laboratoires INELDEA, located in the Mediterranean basin, benefit from recognized technical and scientific expertise in the formulation, development and marketing of natural health products and particularly innovative natural cosmetics.With aproduct portfolio of more than 400 references and a rate of several innovations per year, Laboratoires INELDEA have won, by their consistency and the quality of the products they offer, the confidence of healthcare professionals as well as consumers.Woman, man, child, athlete, each individual at each stage of his life must provide his body with specific elements. It is with this in mind that our brands have been designed.Since health is the most precious good that has been entrusted to us, what is more natural than taking care of it to live as long as possible, to the best of one's physical and intellectual capacities. | $11M / Dec 14, 2017 | |
|
Laboratoires Ineldea
|
Created by a management team with more than 20 years' experience in the field of natural products, Laboratoires INELDEA, located in the Mediterranean basin, benefit from recognized technical and scientific expertise in the formulation, development and marketing of natural health products and particularly innovative natural cosmetics.With aproduct portfolio of more than 400 references and a rate of several innovations per year, Laboratoires INELDEA have won, by their consistency and the quality of the products they offer, the confidence of healthcare professionals as well as consumers.Woman, man, child, athlete, each individual at each stage of his life must provide his body with specific elements. It is with this in mind that our brands have been designed.Since health is the most precious good that has been entrusted to us, what is more natural than taking care of it to live as long as possible, to the best of one's physical and intellectual capacities. | $11M / Dec 14, 2017 | |
Ceva Santé Animale
|
Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs. | Jul 28, 2014 | |
|
Ceva Santé Animale
|
Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs. | Jul 28, 2014 |
Co-Investors
About Mérieux Equity Partners
Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.
Mérieux Equity Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Francois Valencony
Managing Partner,/founder & Executive Officer; Managing Partner & Executive Officer
|
|||
Jean-Francois Billet
Senior Partner
|
|||
Jean-Guillaume Lafay
Operating Partner
|
|||
|
Thierry Chignon
Senior Partner
|
|||
Valerie Calenda
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Thierry Chignon invest in?
Thierry Chignon invests primarily in Beauty, Cannabis and Veterinary startups, most often at Funding Round stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Thierry Chignon last invest?
The most recent investment recorded for Thierry Chignon closed in Dec 2017. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
